Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Ependymoma × fenofibric acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Medulloblastoma 1 Ependymoma 1

Interventions

Magnetic Resonance Spectroscopy 9 Bevacizumab 9 Temozolomide 8 Cyclophosphamide 8 Etoposide 7 X-Rays 6 Phantoms, Imaging 6 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Irinotecan 4 Filgrastim 4 Cisplatin 4 Carboplatin 4 Biopsy 4 Radiotherapy 3 Erlotinib Hydrochloride 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 sargramostim 2 palbociclib 2 olaparib 2 larotrectinib 2 ivosidenib 2 etoposide phosphate 2 erdafitinib 2 ensartinib 2 Vincristine 2 Vemurafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡